EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review

Shahd A Ageeb, Alaa Abdelmoghith, Hager ElGeed, Ahmed Awaisu iD, Abdulmoniem ElMansor, Yaw B Owusu iD

Pharmacoepidemiology and Drug Safety · 2024-08 · 33 (8)

DOI: 10.1002/pds.5879 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 13.08.2024. Verfasst von Shahd A Ageeb und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Practice, College of Pharmacy, QU Health, Qatar University, Doha, Qatar. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Statins are widely prescribed for cardiovascular diseases (CVD) prevention; however, a significant proportion of users discontinue the medication for various reasons. This review aimed to determine the prevalence of statin therapy discontinuation, its associated factors, and adverse cardiovascular outcomes within the first year of discontinuation.

Methods

The PubMed, EMBASE, ScienceDirect, SCOPUS, and Google Scholar databases were systematically searched from their inception to December 2022. Manual searches were also conducted on the bibliographies of relevant articles. Studies were included for qualitative data synthesis and assessed for methodological quality.

Results

Fifty‐two studies, predominantly cohort studies ( n = 38), involving 4 277 061 participants were included. The prevalence of statin discontinuation within the first year of statin initiation ranged from 0.8% to 70.5%, which was higher for primary prevention indications. Factors frequently associated with an increased likelihood of statin discontinuation included male sex, nonWhite ethnicity, smoking status, and being uninsured. Conversely, discontinuation was less likely in patients with CVD who received secondary prevention statin therapy and in patients with polypharmacy. Furthermore, age showed diverse and inconsistent relationships with statin discontinuation among various age categories. Five studies that reported the cardiovascular risk of statin discontinuation within the first year of initiation showed significantly increased risk of discontinuation, including all‐cause mortality (hazard ratio: 1.36–3.65).

Conclusion

Our findings indicate a high prevalence of statin discontinuation and an increased likelihood of adverse cardiovascular outcomes within the first year of discontinuation, despite wide variability across published studies. This review highlights the importance of addressing the modifiable risk factors associated with statin discontinuation, such as smoking and lack of insurance coverage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesHydroxymethylglutaryl-CoA Reductase InhibitorsFemaleHumansMaleAge FactorsPrevalencePrimary PreventionRisk FactorsSecondary Prevention

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Practice, College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
  • Al Khor Health Center, Primary Health Care Corporation, Doha, Qatar.

ORCID-Profile: Ahmed Awaisu, Yaw B Owusu

Förderung

  • Qatar University

Zitieren

APA

Ageeb, S. A., Abdelmoghith, A., ElGeed, H., Awaisu, A., ElMansor, A., & Owusu, Y. B. (2024). Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review. Pharmacoepidemiology and Drug Safety, 33(8). https://doi.org/10.1002/pds.5879

Vancouver

Ageeb SA, Abdelmoghith A, ElGeed H, Awaisu A, ElMansor A, Owusu YB. Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review. Pharmacoepidemiology and Drug Safety. 2024;33(8). doi:10.1002/pds.5879

BibTeX
@article{Ageeb2024,
  author = {Ageeb, Shahd A and Abdelmoghith, Alaa and ElGeed, Hager and Awaisu, Ahmed and ElMansor, Abdulmoniem and Owusu, Yaw B},
  title = {Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  volume = {33},
  number = {8},
  doi = {10.1002/pds.5879}
}
Kostenlos starten →